Inovio Pharma (INO) – Reuters
-
U.S. FDA lifts clinical hold on Inovio's COVID-19 vaccine trial
-
Stock lenders wince as hedge funds lose their shorts
-
U.S., European COVID-19 vaccine developers pledge to uphold testing rigour
-
Wall Street shifts bets to big pharma as COVID-19 vaccine race progresses
-
Inovio's COVID-19 vaccine candidate shows promise in small early-stage trial
-
Moderna rally loses steam over COVID-19 vaccine worries
-
Human trials of British coronavirus vaccine to reach 10,000
-
U.S. Senate leader says will try again to pass Zika bill
-
Senate approves $1.1 billion to fight Zika virus
-
House approves $622 million to combat Zika virus
-
Zika vaccine shows promise in mice, lifting maker Inovio
-
Race for Zika vaccine gathers momentum as virus spreads
Back to INO Stock Lookup